SEC Form 4 · accession 0000899243-17-010223
Dicerna Pharmaceuticals Inc · DRNA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Adam Koppel
Director · 10% Owner
Period of report
Apr 11, 2017
Accepted (ET)
Apr 13, 2017 · 4:46 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001399529
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to buy)F1 | $3.47 | Apr 11, 2017 | A | 25,000 | A | — | Apr 11, 2027 | Common Stock | 25,000 | 25,000 | D |
Explanation of responses
- F1The option vests as to one-third of the underlying shares on April 11, 2018 and as to the remaining two-thirds of the underlying shares in eight equal quarterly installments thereafter.